Market Research Logo

Global Injectable Drugs Market 2017-2021

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Market scenario: Global injectable drugs market 2016
    • ROA
      • Table Decisive factors for the choice of ROA
      • Table Major ROA for drugs intake
      • Table Types of injections
      • Table Adverse effects of injectable drugs
  • Market landscape
    • Market overview
      • Table Global injectable drugs market snapshot
    • Market size and forecast
      • Table Global injectable drugs market 2016-2021 ($ billions)
      • Table Opportunity analysis in global injectable drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline molecules by key vendors (Phase III)
    • Table Key clinical trials of key vendors (Phase III)
  • Market segmentation by molecule type
    • Table Global injectable drugs market segmentation by molecule type
    • Table Global injectable drugs market segmentation by molecule type 2016 and 2021 (%)
    • Biologics
      • Table Global biologics injectable drugs market 2016-2021 ($ billions)
      • Table Top biologic drugs in the injectable drugs market
    • Small molecules
      • Table Global small molecules injectable drugs market 2016-2021 ($ billions)
  • Geographical segmentation
    • Table Segmentation of global injectable drugs market based on geography 2016 and 2021 (%)
    • Table Global injectable drugs market by geography 2016-2021 ($ billions)
    • Injectable drugs market in Americas
      • Table Market scenario in Americas
      • Table Injectable drugs market in Americas 2016-2021 ($ billions)
    • Injectable drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Injectable drugs market in EMEA 2016-2021 ($ billions)
    • Injectable drugs market in APAC
      • Table Market scenario in APAC
      • Table Injectable drugs market in APAC 2016-2021 ($ billions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Major indications finding huge applications of injectable drugs
      • Table Major reasons to use injectable drugs
      • Table New cases of diabetes by 2040
    • Market challenges
      • Table Major complications involved with the injections
      • Table Major causes of drug shortage
  • Market trends
    • Rising awareness leading to high demand for injectable drugs
    • Increase in industry-academia collaboration
    • Expected entry of novel vaccines
    • Advent of biosimilars
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global injectable drugs market
  • Key vendor analysis
    • AbbVie
      • Table AbbVie: Key highlights
      • Table AbbVie: Strength assessment
      • Table AbbVie: Strategy assessment
      • Table AbbVie: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Global Injectable Drugs Market 2017-2021

About Injectable Drugs

Injectable drugs are directly infused into the body with the help of a syringe and a hollow needle. Various modes of infusion are used for the drug delivery. Among them, subcutaneous (SC), intramuscular (IM), and intravenous (IV) are the three major modes. The market encompasses drugs that are used for the prevention and cure of various diseases, and are mainly of two types, namely, biologics and small molecule drugs.Technavio’s analysts forecast the global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global injectable drugs market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
Other prominent vendors
  • Bayer
  • Bristol-Myers Squibb
  • Merck
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
Market driver
  • Escalation in demand for self-injection devices
  • For a full, detailed list, view our report
Market challenge
  • High cost of production
  • For a full, detailed list, view our report
Market trend
  • Increase in industry-academia collaboration
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Releases

Technavio Announces the Publication of its Research Report – Global Injectable Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global injectable drugs market: AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, and Sanofi.

Other Prominent Vendors in the market are: Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase in industry-academia collaboration. The key players in the injectable drugs market, especially vaccines market, are increasingly extending their support to academic institutions to support the R&D of innovative products for diabetes care. Such collaborations enable the amalgamation of research expertise of academic institutions with the marketing intelligence of pharma companies, besides providing funds for conducting the trial studies.”

According to the report, one driver in the market is escalation in demand for self-injection devices. There has been a rise in the demand for self-injection devices in the recent years, owing to the factors such as the high demand for diabetes and other hormone replacement therapies. Diabetes is turning to be one of the most serious health concerns in the people across the world. It was estimated that, in 2015, approximately 400-425 million of the adult population were having diabetes. If this uncontrolled blood sugar stays for a longer period, it can affect the quality of life and can even lead to a slow death in longer duration. For instance, around 1.45 million people die due to diabetes each year.

Further, the report states that one challenge in the market is high cost of production. The injectable drugs come up with high operational costs, which further increases the final cost of the products. There are a large number of factors, which contribute to the high price of the injectable drugs, more specifically the vaccines. It was estimated that the development of a single vaccine costs around $1 billion-$2 billion. High failure rates associated with vaccine development are majorly responsible for the increased production cost of the vaccines. The approval rate by the FDA is extremely low compared with the number of molecules present in the clinical trials.

Companies Mentioned

AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, Sanofi, Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;